Abiraterone-acetate/prednisone/radium-223-chlorideNeutropenia and fracture: 3 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1831卷 / 1期
关键词：
D O I：
10.1007/s40278-020-86270-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：14 / 14
相关论文
共 50 条
  • [41] Prednisone/rituximabTendonitis: 3 case reports
    Reactions Weekly, 2017, 1673 (1) : 304 - 304
  • [42] ERA 223: A phase 3 trial of radium-223 dichloride in combination with abiraterone acetate and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-na ve patients with bone-predominant metastatic castration-resistant prostate cancer.
    Smith, Matthew R.
    Parker, Chris C.
    Tombal, Bertrand F.
    Miller, Kurt
    Saad, Fred
    Shen, Junwu
    Zhang, Amily
    Kornacker, Martin
    Higano, Celestia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 20, pg 408, 2019)
    Smith, M.
    Parker, C.
    Saad, F.
    LANCET ONCOLOGY, 2019, 20 (10): : E559 - E559
  • [44] Radium-223-chlorideLeucopenic infection, thrombocytopenia and intracranial haemorrhage: 2 case reports
    Reactions Weekly, 2017, 1677 (1) : 228 - 228
  • [45] Prednisone/tacrolimusLeucopenia and fatigue: 3 case reports
    Reactions Weekly, 2017, 1660 (1) : 273 - 273
  • [46] Prednisone/TofacitinibLack of efficacy: 3 case reports
    Reactions Weekly, 2024, 2021 (1) : 457 - 457
  • [47] Prednisone/tacrolimusVarious toxicities: 3 case reports
    Reactions Weekly, 2018, 1707 (1) : 231 - 231
  • [48] Prednisone/thalidomideVarious toxicities: 3 case reports
    Reactions Weekly, 2019, 1765 (1) : 277 - 277
  • [49] A phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)
    Petrylak, D. P.
    Vaishampayan, U. N.
    Patel, K. R.
    Higano, C. S.
    Albany, C.
    Dawson, N. A.
    Mehlhaff, B. A.
    Quinn, D. I.
    Nordquist, L. T.
    Wagner, V. J.
    Shen, J.
    Trandafir, L.
    Sartor, O.
    ANNALS OF ONCOLOGY, 2019, 30 : 340 - 341
  • [50] ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)
    Smith, M. R.
    Parker, C. C.
    Saad, F.
    Miller, K.
    Tombal, B.
    Ng, Q. S.
    Boegemann, M.
    Matveev, V.
    Piulats, J. M.
    Zucca, L. E.
    Heidenreich, A.
    Kakehi, Y.
    Zhang, A.
    Krissel, H.
    Shen, J.
    Wagner, V.
    Higano, C.
    ANNALS OF ONCOLOGY, 2018, 29
12345